Rieder Michael
J Pediatr Pharmacol Ther. 2019 Jan-Feb;24(1):4-9. doi: 10.5863/1551-6776-24.1.4.
An underappreciated problem in child health is the risk for adverse drug reactions (ADRs). While there is an impression that children are at a lower risk than adults for ADRs, in fact a number of factors germane to pediatric therapy place certain groups of children at a high risk for adverse events associated with therapy. Given the importance of drug safety, an understanding of a diagnostic classification for ADRs and of how to approach a possible ADR clinically are key skills for pediatric pharmacists. As drug therapy for children evolves, becomes more complex, and begins to use novel molecules and biologicals there will be an increasing need for pediatric pharmacists to be more involved in clinical care, education, and research specific to drug safety.
儿童健康中一个未得到充分重视的问题是药物不良反应(ADR)的风险。虽然有一种观点认为儿童发生药物不良反应的风险低于成人,但实际上,与儿科治疗相关的一些因素使某些儿童群体面临与治疗相关的不良事件的高风险。鉴于药物安全的重要性,了解药物不良反应的诊断分类以及如何在临床上处理可能的药物不良反应是儿科药剂师的关键技能。随着儿童药物治疗的发展、变得更加复杂,并开始使用新型分子和生物制剂,儿科药剂师将越来越需要更多地参与到特定于药物安全的临床护理、教育和研究中。